Early posttransplant lymphoproliferative disease

American Journal of Clinical Pathology

Volumn 138, Issue 4, 2012, Pages 568-578

  Nelson, Beverly P ^a   Wolniak, Kristy L ^a   Evens, Andrew ^c   Chenn, Anjen ^a   Maddalozzo, John ^a,b   Proytcheva, Maria ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Early posttransplant lymphoproliferative disorder; EBV; Epstein Barr virus; EPTLD; mTOR signaling pathway

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CYCLOSPORIN A; MAMMALIAN TARGET OF RAPAMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN S6; RAPAMYCIN; STEROID; TACROLIMUS;

ADENOID; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EARLY POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE; MALE; MEDICAL RECORD REVIEW; PANCREAS TRANSPLANTATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SIGNAL TRANSDUCTION; TONSIL; VIRUS LOAD;

ADOLESCENT; CHILD; CLONE CELLS; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LYMPHOID TISSUE; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PHOSPHORYLATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RIBOSOMAL PROTEIN S6; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; TOR SERINE-THREONINE KINASES; YOUNG ADULT;

EID: 84866986233     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPQYYE04AVGVYI     Document Type: Article

References (18)

1. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988;133:173-192.
2. Swerdlow S, Webber SA, Chadburn A, et al. Post-transplant lymphoproliferative disorders. In: Swerdlow SH, ed. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008:343-349.
3. Vakiani E, Nandula SV, Subramaniyam S, et al. Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion. Hum Pathol. 2007;38:315-325. (Pubitemid 46096557)
4. Bakker NA, van Imhoff GW, Verschuuren EA, et al. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant. 2005;19:327-334. (Pubitemid 40711965)
5. Roque J, Rios G, Humeres R, et al. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Transplant Proc. 2006;38:930-931.
6. Katz BZ, Pahl E, Crawford SE, et al. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort. Pediatr Transplant. 2007;11:58-65. (Pubitemid 46100956)
7. Zangwill SD, Hsu DT, Kichuk MR, et al. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. J Heart Lung Transplant. 1998;17:1161-1166. (Pubitemid 29013395)
8. Chadburn A, Chen JM, Hsu DT, et al. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer. 1998;82:1978-1987. (Pubitemid 28208656)
9. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85:552-565.
10. Nelson BP, Nalesnik MA, Bahler DW, et al. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol. 2000;24:375-385. (Pubitemid 30127473)
11. Wu TT, Swerdlow SH, Locker J, et al. Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol. 1996;27:157-164. (Pubitemid 26049469)
12. El-Salem M, Raghunath PN, Marzec M, et al. Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders. Lab Invest. 2007;87:29-39. (Pubitemid 44973651)
13. Brodsky L. Modern assessment of tonsils and adenoids. Pediatr Clin North Am. 1989;36:1551-1569. (Pubitemid 20086170)
14. van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317. (Pubitemid 38072572)
15. Sandberg Y, van Gastel-Mol EJ, Verhaaf B, et al. BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics. J Mol Diagn. 2005;7:495-503. (Pubitemid 41479716)
16. Chadburn A, Cesarman E, Liu YF, et al. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms. Cancer. 1995;75:2747-2756.
17. Ho M, Miller G, Atchison RW, et al. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis. 1985;152:876-886. (Pubitemid 16236674)
18. Lones MA, Mishalani S, Shintaku IP, et al. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. Hum Pathol. 1995;26:525-530.